Page last updated: 2024-08-23

etoposide and cardiovascular agents

etoposide has been researched along with cardiovascular agents in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alpert, L; Chalifour, LE; Kirby, GM; Mitmaker, B; Saadane, N; Yue, P	1
Hofland, KF; Jensen, PB; Sehested, M; Thougaard, AV	1

Other Studies

2 other study(ies) available for etoposide and cardiovascular agents

Article	Year
Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice. Canadian journal of physiology and pharmacology, 2001, Volume: 79, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Cardiovascular Agents; DNA; DNA-Binding Proteins; Doxorubicin; Early Growth Response Protein 1; Etoposide; Female; Gene Expression Regulation; Immediate-Early Proteins; Mice; Phenotype; Razoxane; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors	2001
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-15, Volume: 11, Issue:10 Topics: Anemia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cell Culture Techniques; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Etoposide; Female; Leukopenia; Mice; Neutropenia; Razoxane; Thrombocytopenia	2005

Article

Year

Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.

Canadian journal of physiology and pharmacology, 2001, Volume: 79, Issue:6

Topics: Animals; Antibiotics, Antineoplastic; Cardiovascular Agents; DNA; DNA-Binding Proteins; Doxorubicin; Early Growth Response Protein 1; Etoposide; Female; Gene Expression Regulation; Immediate-Early Proteins; Mice; Phenotype; Razoxane; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors

2001

Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-15, Volume: 11, Issue:10

Topics: Anemia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cell Culture Techniques; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Etoposide; Female; Leukopenia; Mice; Neutropenia; Razoxane; Thrombocytopenia

2005